Economic Evaluation in Genomic Medicine

Erscheinungsjahr 2015
ISBN: 978-0-12-801497-4
Verlag: Elsevier Health Sciences

Buch, Englisch, 174 Seiten, Format (B × H): 152 mm x 226 mm, Gewicht: 295 g

Economic Evaluation in Genomic Medicine introduces health economics and economic evaluation to genomic clinicians and researchers, while also introducing the topic to health economists.

Each chapter includes an executive summary, questions, and case studies, along with supplementary online materials, including process guides, maps, flow charts, diagrams, and economic evaluation spreadsheets to enhance the learning process.

The text can easily be used as course material for related graduate and undergraduate courses, providing a succinct overview of the existing, state-of-the-art application of economic evaluation to genomic healthcare and precision medicine.

Zielgruppe

Bioscientists, geneticists, biotech industry professionals, undergraduate and graduate students in health economics and health sciences, namely medicine, pharmacy, genetics, clinicians and health managers, public health officers, health policy makers, governmental organizations, health care professionals, hospital managers, healthcare policy makers

Autoren/Hrsg.

Fragoulakis, Vasilios

Mitropoulou, Christina

Williams, Marc

Patrinos, George P

Fachgebiete

• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie Medizinische Biotechnologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
• Wirtschaftswissenschaften Volkswirtschaftslehre Volkswirtschaftslehre Allgemein Mikroökonomie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik

Inhaltsverzeichnis

1. Economic evaluation in healthcare: Evidence-based medicine and evidence-based health economics2. Genomic Medicine today: an introduction for health economists3. Economic evaluation and genomic medicine: What can they learn from each other?4. Introduction to the technical issues of economic evaluation5. Advanced methodological aspects in the economic evaluation 6. Economic evaluation in the genomic era: Some examples from the field7. Special requirements for economic evaluation and health technology assessment in genomic medicine 8. A new methodological approach for cost-effectiveness analysis in Genomic Medicine9. Conclusions and future perspectives

Über Autor(innen)

Mitropoulou, Christina
Christina Mitropoulou is Managing Director and Principal Investigator at the Golden Helix Foundation (London, UK), a registered UK-Charity with Research and Educational activities in the field of Genomic and Personalized Medicine. Her research interests revolve around the health economic evaluation of genome-guided therapeutic interventions. Also, Christina Mitropoulou participates as Executive Committee member of the Ubiquitous Pharmacogenomics (U-PGx) project and coordinates the health economic evaluation of the PREPARE clinical study on pre-emptive Pharmacogenomics testing, involving approx. 8000 patients from 7 clinical sites and she is an active member of the Pharmacogenomics Access and Reimbursement Coalition.
Christina Mitropoulou has published several original articles on this topic in leading scientific journals and has edited two textbooks on economic evaluation in Genomic Medicine that are published by Elsevier/Academic Press.